Price $240.77 |
Market Cap
36.37B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
118.5
|
P/B
20.1
|
P/S
30.25
|
Dividend %
-
|
|
P/CF
267.6
|
P/FCF
-
|
Op. Cash Flow
483.3K
|
FCF
-
|
|
Op. Margin
25.30%
|
Net Margin
26.30%
|
ROE
19.40%
|
ROI
16.40%
|
|
ROA
14.90%
|
EPS Growth
18.80%
|
Current Ratio
2.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acura Pharmaceuticals, Inc. (ACUR) | $0.30 | - | - | 7.5M | Strong Buy |
| Pacific Biosciences of Califor (PACB) | $3.79 | - | - | 556.3M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $7.36 | - | 0.10% | 476.3M | Strong Buy |
| Champions Oncology Inc (CSBR) | $8.80 | - | - | 114.4M | Strong Buy |
| International Stem Cell Corp (ISCO) | $0.70 | - | - | 6.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
